N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.226 NOK 2.68% Market Closed
Market Cap: 726.9m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nykode Therapeutics ASA
Other Operating Expenses Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Other Operating Expenses
-$32.5m
CAGR 3-Years
-11%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Other Operating Expenses
-kr84.8m
CAGR 3-Years
-16%
CAGR 5-Years
-19%
CAGR 10-Years
-8%
B
Bergenbio ASA
OSE:BGBIO
Other Operating Expenses
-kr102.8m
CAGR 3-Years
24%
CAGR 5-Years
7%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Other Operating Expenses
-kr12.3m
CAGR 3-Years
-61%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Other Operating Expenses
-kr34.4m
CAGR 3-Years
-33%
CAGR 5-Years
-15%
CAGR 10-Years
-9%
T
Thor Medical ASA
OSE:TRMED
Other Operating Expenses
-kr11.7m
CAGR 3-Years
66%
CAGR 5-Years
47%
CAGR 10-Years
9%

See Also

What is Nykode Therapeutics ASA's Other Operating Expenses?
Other Operating Expenses
-32.5m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Other Operating Expenses amounts to -32.5m USD.

What is Nykode Therapeutics ASA's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-67%

Over the last year, the Other Operating Expenses growth was 28%. The average annual Other Operating Expenses growth rates for Nykode Therapeutics ASA have been -11% over the past three years , -67% over the past five years .

Back to Top